EUVIMEDEUVIMED entdecken
Crossref

Safety and Efficacy of 90 Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience

Cherie Wei Qi Ng, Muhammad Jai Bin Hassan, Charles Goh, Aaron Kian Ti Tong, Wei Ying Tham, Sue Ping Thang, Winnie Wing-Chuen Lam, Han Chung Low, Butch M Magsombol, Kelvin Siu Hoong Loke

Journal of Nuclear Medicine Technology · 2024

DOI: 10.2967/jnmt.123.265967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine Technology, 2024. Verfasst von Cherie Wei Qi Ng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore, Singapore; and. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Microspheres, Yttrium Radioisotopes. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our objective was to demonstrate primarily the safety and secondarily the efficacy of 90Y glass microspheres in selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC) in a local Southeast Asian hospital.

Methods

Eleven consecutive patients with small, unresectable, nonmetastatic HCC and referred for locoregional therapy with SIRT with a curative intention were followed up for 6 mo after the procedure by way of interviews, blood tests, and anatomic scans.

Results

Although 5 patients had deranged liver function tests after the procedure, in only 1 patient did this constitute a grade 1 toxicity (in alkaline phosphatase) by the Common Terminology Criteria for Adverse Events. Half the patients showed a reduction in serum α-fetoprotein measurements, and 6 of 11 patients demonstrated an objective response (complete or partial) on imaging.

Conclusion

SIRT with 90Y glass microspheres is a safe and efficacious locoregional therapy for unresectable HCC. There are similar articles published in the West; however, the patient population there comprises far fewer Asians and the underlying cause for HCC is different from that in the Asian population. Despite these differences, SIRT is an equally effective and safe option for such patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicrospheresYttrium RadioisotopesGlassHumansMaleMiddle AgedFemaleAgedTreatment OutcomeSafetyAsia, SoutheasternSoutheast Asian People

Stichwörter der Autor:innen

90Yhepatocellular carcinomaselective internal radiation therapy

Substanzen

Yttrium RadioisotopesYttrium-90

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore, Singapore; and.
  • Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore, Singapore; and drkelvinloke@yahoo.com.

Zitieren

APA

Ng, C. W. Q., Bin Hassan, M. J., Goh, C., Tong, A. K. T., Tham, W. Y., Thang, S. P., Lam, W. W., Low, H. C., Magsombol, B. M., & Loke, K. S. H. (2024). Safety and Efficacy of 90 Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience. Journal of Nuclear Medicine Technology. https://doi.org/10.2967/jnmt.123.265967

Vancouver

Ng CWQ, Bin Hassan MJ, Goh C, Tong AKT, Tham WY, Thang SP, et al. Safety and Efficacy of 90 Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience. Journal of Nuclear Medicine Technology. 2024. doi:10.2967/jnmt.123.265967

BibTeX
@article{Ng2024,
  author = {Ng, Cherie Wei Qi and Bin Hassan, Muhammad Jai and Goh, Charles and Tong, Aaron Kian Ti and Tham, Wei Ying and Thang, Sue Ping and Lam, Winnie Wing-Chuen and Low, Han Chung and Magsombol, Butch M and Loke, Kelvin Siu Hoong},
  title = {Safety and Efficacy of 90 Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience},
  journal = {Journal of Nuclear Medicine Technology},
  year = {2024},
  doi = {10.2967/jnmt.123.265967}
}
Kostenlos starten →